Please assess the completion status of the following clinical trial:

Trial Title: Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* age over 18 year old~* Cochin Hand Function Scale (CHFS) \> 20/90~Exclusion Criteria:~* new vasodilators or immunosuppressive therapy for SSc in the 3 months prior to enrolment~* new vasodilators or immunosuppressive therapy for SSc during the 6-month follow-up~* clinical or radiological signs of digital infection~* positive status for HIV~* positive status for hepatitis B or C~* positive status for human T-cell leukemia virus 1-2~* positive status for syphilis~* pregnancy~* BMI less than 17kg/m2

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SVF injection (Type: EXPERIMENTAL): SVF was obtained from lipoaspirates, using an automated processing system, and subsequently injected into the subcutaneous tissue of each finger in contact with neurovascular pedicles

Based on this trial design, predict the completion outcome and termination type (if applicable).